Global Dry Eye Syndrome Market Expected to Reach USD 8.0 Billion by 2033 - IMARC Group

Global Dry Eye Syndrome Market Statistics, Outlook and Regional Analysis 2025-2033

The global dry eye syndrome market size was valued at USD 5.0 Billion in 2024, and it is expected to reach USD 8.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.78% from 2025 to 2033.

The market is being shaped by consolidation as businesses look to improve their market position and increase the range of products they offer. This approach strengthens the industry by demonstrating a drive to satisfy growing demand and offer complete eye care solutions. For example, in March 2022, Théa, a U.S.-based eye care product company, completed the acquisition of multiple ophthalmic products from Akorn Operating Company LLC. 

Moreover, strategic acquisitions are helping the market thrive as organizations aim to increase their market share and diversify their holdings. This strategy meets the growing need for all-inclusive eye care solutions while facilitating wider access to specialty items. For instance, in August 2022, Nicox S.A. announced plans to advance the development of NCX 4251, a novel ophthalmic suspension of fluticasone propionate nanocrystals, as a treatment for dry eye disease. This decision followed positive post hoc results from the Mississippi Phase 2b clinical trial, which indicated that once-daily dosing of NCX 4251 effectively reduced dry eye symptoms in a subset of patients.  Furthermore, the market for dry eye syndrome is expanding as businesses manufacture new goods to satisfy customers' demands for efficient and long-lasting treatment. The need for cutting-edge treatments, including tear-stimulating solutions and formulas free of preservatives, is fueling innovation. The aging population and the usage of digital devices, which are the main causes of dry eye diseases, have prompted the market in Asia Pacific to adopt innovative goods. Leading companies are concentrating on R&D to produce distinctive solutions that are compatible with local needs. For example, by lowering inflammation and enhancing tear quality, Santen Pharmaceutical Co. Ltd. has launched Ikervis (ciclosporin) eye drops in a number of Asia Pacific nations, addressing a critical need in areas with high rates of age-related dry eye problems and screen-related eye strain.

Global Dry Eye Syndrome Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest dry eye syndrome market share, on account of an advanced healthcare infrastructure, which ensures easy access to specialized eye care facilities and experienced professionals.

North America Dry Eye Syndrome Market Trends:

Prescription eye drops are becoming more popular in North America as screen-related eye strain becomes more common, thereby exhibiting regional dominance. For example, Xiidra (lifitegrast) has gained popularity as a treatment for dry eyes, in response to increased digital device usage.

Europe Dry Eye Syndrome Market Trends:

As consumer awareness grows, the Europe region prioritizes natural and preservative-free products. Thealoz Duo, a preservative-free eye drop, is popular among patients seeking safer, long-term comfort that adheres to rigorous EU safety regulations.

Asia Pacific Dry Eye Syndrome Market Trends:

The Asia Pacific region is experiencing an increase in innovative treatments for dry eye illness. Diquafosol tetrasodium ophthalmic solution has been approved and widely used in Japan, providing patients with a specialized medication that increases tear and mucus production, addressing the country's high prevalence of dry eye.

Latin America Dry Eye Syndrome Market Trends:

Due to financial limitations, Latin America is concentrating on affordable treatment options. Economical and over-the-counter lubricating eye drops are becoming more popular for wider accessibility in Brazil, where dry eye illness is prevalent at about 13%.

Middle East and Africa Dry Eye Syndrome Market Trends:

In order to fight arid regions, the focus is on treatments that maintain moisture in the Middle East and Africa. In Saudi Arabia, where 32.1% of individuals suffer from dry eye and humidifiers are common remedies for symptoms brought on by dry surroundings.

Top Companies Leading in the Dry Eye Syndrome Industry

Some of the leading dry eye syndrome market companies include Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co., Ltd., and Santen Pharmaceutical Co., Ltd., among many others. For example, in September 2021, Bausch + Lomb Incorporated collaborated with Novaliq Gmbh to develop a new drug, NOV03, for the treatment of dry eye disease.

Global Dry Eye Syndrome Market Segmentation Coverage

• On the basis of the disease type, the market has been bifurcated into evaporative dry eye syndrome and aqueous dry eye syndrome, wherein evaporative dry eye syndrome represents the most preferred segment. It dominates the market due to its higher rate of incidence than other kinds of dry eye disease.
• Based on the drug type, the market is categorized into anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops, amongst which anti-inflammatory drugs dominate the market due to their efficacy in addressing the underlying inflammation associated with dry eye disease.
• On the basis of the product, the market has been divided into liquid drops, gel, liquid wipes, eye ointment, and others. Among these, liquid drops exhibit a clear dominance in the market as they can be quickly and effortlessly taken by patients, offering instant relief from symptoms.
• Based on the distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies, wherein hospital pharmacies dominate the market on account of the trust and credibility associated with hospital-based healthcare.

Browse IMARC Related Reports on Dry Eye Syndrome Market:

• North America Dry Eye Syndrome Market Report
   
• Latin America Dry Eye Syndrome Market Report
   
• Europe Dry Eye Syndrome Market Report
   
• United States Dry Eye Syndrome Market Report
   
• Asia Pacific Dry Eye Syndrome Market Report